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1. Introduction 
Alzheimer’s disease (AD) is a progressive, neuro-degenerative disease, which is clinically 
characterized by loss of memory and progressive deficits in different cognitive domains. 
Widespread epidemic, long-term treatment and high medical costs have made AD a major 
public health problem.  
AD is associated with low in vivo level of acetylcholinesterase. The consistent neuropathologic 
hallmark of the disorder is a massive deposit of aggregated protein degradation products, 
amyloid-β (Aβ) plaques and neurofibrillary tangles (Haviv et al., 2005). Even if the primary 
cause of AD is still speculative, Aβ aggregates are thought to be mainly responsible for the 
pathogenesis of the disease (Hardy & Selkoe, 2002). In recent years, significant research has 
been devoted to the role of free radical formation, oxidative cell damage, and inflammation 
in the pathogenesis of AD, providing new promising targets and validated animal models 
(Capsoni et al., 2000).  
The major marketed drugs for the symptomatic treatment of AD are acetylcholinesterase 
(AChE) inhibitors, that is, tacrine (TC) (Davis & Powchik, 1995), donepezil (Bryson & 
Benfield, 1997), rivastigmine (Gabelli, 2003), and galantamine (Sramek et al., 2000) which 
inhibit AChE activity to promote an increase in the concentration and the duration of 
acetylcholine in the brain. However, they do not address the etiology of the disease.  
The crystal structure of Torpedo California AChE (TcAChE) revealed that its active site lies 
at the bottom of a deep and narrow gorge (20 Å), named the “active site gorge” or “aromatic 
gorge” (Axelsen, 1994), the schematic can be seen in the Fig. 1. At the active site, the catalytic 
triad Ser200-His440-Glu327 is responsible for hydrolyzing the ester bond in ACh. At the 
“anionic” subsite of the active site (historically termed the “catalytic anionic site”, CAS), 
consisting of Trp84, Tyr130, Gly199, His441 and His444 amino acid residues, adjacent to the 
catalytic triad, the indole side chain of the conserved residue Trp84 makes a cation-π 
interaction with the quaternary amino group of ACh. (Ma, 1997) A second aromatic residue, 
Phe330, is also involved in the recognition of ligands. The conserved residue Trp279 is the 
major component of a second binding site, named the peripheral “anionic” site (PAS), 
consisting of Tyr70 ,ASP72, Tyr121,Trp279 and Tyr334 amino acid residues, 14 Å from the 
active site, near the top of the gorge. (Harel, 1993) The oxyanion hole formed by the peptidic 
amino groups of Gly118, Gly119, Ala201 amino acid residues is another important 
functional unit in the esteratic subsite (Wiesner et al., 2007). 
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Fig. 1. The active site of AchE 
Recently the peripheral anionic site (PAS) of AChE has been indicated to be involved in Aβ 
peptide aggregation and formed a steady compound with Aβ. On the basis of these 
premises, AChE inhibitors, which may alleviate cognitive deficits and behave as disease-
modifying agents by inhibiting the β-amyloid (Aβ) peptide aggregation through binding to 
both catalytic and peripheral sites of the enzyme are becoming a new field for AD therapy.  
Traditional medicine Corydalis caca has been embodied by Chinese Pharmacopoeia with 
the function of promoting blood circulation, relieving the pain and strengthening immunity. 
Ma et al. had extracted and isolated eight kinds of Tetrahydroisoquinoline alkaloids from 
the herb Corydalis, including Corydaline (Ma, 2008). The rigid structure containing the unit 
of Tetrahydroisoquinoline was shown in Fig. 2 (a). Adserson et al. found the methanol 
extract of Corydalis caca showing a potential inhibitory effects on the AChE activity, 
especially Corydaline, which is not sensible to BChE (IC50>100 μM) has the highest activity 
(IC50<15 μM) and selectivity among the alkaloids isolated(Adsersen et al., 2007). Because 
of its well-established biological properties, a type of cordalis alkaloid corydaline, which has 
demonstrated moderate inhibition to AChE, was used as a lead compound to obtain the 
action mechanism of corydaline to AChE and screen a series of its open ring derivatives by 
means of molecular docking and virtual screen.  
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Fig. 2. Structure of Corydaline (a) and compound 7(b) 
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Molecular docking method (GOLD) was used by us to investigate the binding mode of 
corydaline with acetylcholinesterase and to screen a series of open ring derivatives with 
different carbon linkages and different substituent groups. Molecular Dynamics research 
has been done by us between the Corydaline and TcAChE with the open conformation, 
semi-open conformation and close conformation respectively. The best result was obtained 
by GOLD when corydaline was bound to the enzyme catalytic site in the open 
conformation. The conformation model in Fig. 5(a) indicates that phenyl ring A interacts 
with the phenyl group of Tyr 334 via a classic parallel π-π accumulation and that the 
positively charged nitrogen atom interacts with the phenyl group of Phe 330 in the 
hydrophobic site by the cation-π effect. Phenyl D that penetrate to the catalytic position at 
the bottom of the active pocket, interacts with Trp 84 via π-π effect.  
Based on our former research, Yuren Jiang, et al. designed and screened a series of 
compounds, in which, the virtual molecule 7 was synthesized and assayed the inhibitory 
activity for AChE ( IC50=473.3 nM•L-1) (Yuren et al., 2009).The structure of virtual 
molecule 7 was shown in the Fig. 2 (b). Virtual screening showed that the scores of most 
derivatives were higher than that of corydaline, and the open ring substances with the 
highest scores were mainly derived from those substituted by phenoxy groups and those 
with 2- to 7- carbon linkages.  
On account of the chemical structure of Corydaline is consisted of rigid fusedheterocycle, 
The length of molecule was too short to reach both the catalytic anionic site and the 
peripheral “anionic” site, We decided to use Corydaline as lead compound. In the reserves 
of Protons turn nitrogen, The C ring of Corydaline was opened in order to get derivatives 
that were based on the Tetrahydroisoquinoline structure. The virtual ligands with the 
respective substituent groups of -OH, -OCH3, benzyl ect. and different length with 2- to 7- 
linkages were designed from alkaloids of Corydaline as potential acetylcholinesterase 
inhibitors. Such derivatives are able to interact with both catalytic anionic site and PAS in 
the TcAChE. Such design may increase the flexibility and affinity of the virtual ligands to 
interact with both central catalytic site and peripheral site in the TcAChE more favourably. 
The designed analogs of tetrahydroisoquinoline derivatives as showed in Fig. 3.  
 
 
Fig. 3. The designed analogs of tetrahydroisoquinoline derivatives 
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2. Materials and methods  
A comparison of several docking methods was carried out (Xie et al., 2006). With the 
purpose of investigating which docking method was more suitable for the AChE inhibitors, 
and the results indicated that GOLD (Jones et al., 1997) reproduced the X-ray determined 
conformations of known AChE inhibitors better than others. Therefore, GOLD version 
3.0.1(Jones et al., 1997) was employed to probe into the binding mode between AChE and its 
inhibitors. 
2.1 Acquisition of the AChE conformation 
The crystal structure of the complex with hAChE and ligand has not been reported yet, 
However, Account for the sequence identity of hAChE and TcAChE is as high as 50 percent 
(Wiesner et al., 2007), as the Fig. 4 shows, TcAChE that obtained from the Protein Data 
Bank(Berman et al., 2000), can be chosen as protein acceptor. The process of the AChE 
conformation is to import the crystal structure of TcAChE (1EVE) to SYBYL 7.3 (Tripos Inc, 
2006), delete the ligand and water molecule in the complex by using the Built/Edit module. 
Then add the hydrogen atom and AMBER charges to all amino acid residues by using the 
Biopolymer module. Save the conformation as the format of MOL2 for docking preparation.  
 
Fig. 4. 3-D alignment of human 1B41, mouse 1N5M and torpedo 1EA5 structures 
2.2 Acquisition and optimization of the ligands 
Corydaline and the open ring derivatives which have been designed were sketched in the 
Build/Edit module of SYBYL7.3.The type of the atoms and bonds in the ligands were 
modified to make sure they could be well- distinguished by the docking software. Then add 
the hydrogen atom to the ligands by using the Built/Edit module, and in the Calculation 
module, the charge of Gasteiger-Hukel was added to the ligands. Tripos molecular force 
field algorithm was chosen to modify the ligands by 3000 steps molecular mechanics 
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optimization, Powell was chosen as iterative algorithm, and the energy gradient termination 
condition of the iteration was set to 0.005 kJ/(mol•nm). The key interaction truncation 
value was set to 1.0 nm, dielectric constant was set to 1, and other parameters were for 
default. Save the ligand conformations as the fomat of MOL2 for docking preparation.  
2.3 Molecule docking and virtual screening 
The active site was defined as all the residues within 10Å from the original ligand molecule. 
The default parameters of genetic algorithms (GA) were applied to search the reasonable 
binding conformation of these flexible ligands. The maximum number of GA runs was set to 
600 for each compound. Early termination was allowed if the root mean square deviation 
(RMSD) of top 3 solutions are within 0.15 nm. The GOLDScore fitness function was used to 
evaluate the docking conformations and only energetically favourable conformations were 
selected for further analysis. These docked conformations were saved in MOL2 format.  
2.4 Image display and data analysis 
The ligand that got the highest Fitness Score in MD and the TcAChE conformation were 
imported into Silver at the same time, “show hydrogen bond” option was chosen to display 
the hydrogen bonds, “show close contracts” option was chosen to display the distance 
between the close atoms, and “Measure” option was chosen to calculate Hydrogen bonding 
Angle as well as the distance and Angle of hydrophobic interaction.  
3. Results and discussion 
Virtual screening showed that the scores of most derivatives were higher than that of 
corydaline, and the 10 open ring substances with the highest scores were mainly derived 
from those substituted by benzyl, methoxyl, hydroxymethyl groups, ect, and those with 2- 
to 7- carbon linkages. The main interactions between the ligands and the acceptor were 
hydrophobic interaction and hydrogen bond. The Rank and Fitness Score of the top 10 
tetrahydroisoquinoline derivatives can be seen from the Table 1, in which, the Fitness score 
is a comprehensive evaluation of Van der Waals' force as well as hydrogen bond, 
considering both intramolecular and intermolecular interaction. The higher score the ligand 
got, represented the better affinity, the smaller IC50 and the stronger inhibitory activity. The 
results of molecule docking and interaction analysis showed that: all of the derivatives listed 
in Table 1 could interact with muti-active sites in TcAChE. In instance, the compound 8a 
could bind with both catalytic site and PAS at the same time, that as shown in the Fig. 5(b).  
Molecular modelling obtained by GOLD suggests that, in the compound 8a, the phenyl 
group A of the derivatives buried within the core of the enzyme binds with the catalytic site 
via face-to-face π- stacking interaction (distance: 3.155Å) with Trp84. The phenyl group B 
reaches the peripheral site on the surface of the enzyme by face-to-face π-stacking 
interaction (distance: 3.225 Å) with Trp279.The protonated nitrogen atom of the 
tetrahydroisoquinoline moiety interacts with the phenyl group of Phe330 by cation-π 
interaction (distance: 4.021 Å). The phenyl group of the tetrahydroisoquinoline moiety 
interacts with Tyr334 by a classic parallel π-π accumulation (distance: 3.818 Å). The distance 
between the phenyl group A and B is 13.225 Å, which is similar to the distance that had been 
reported between the Trp84 and Trp279 (Harel et al., 1993).  
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According to the comparison of the binding mode between the Compound 8a and 
Corydaline, The increase has been found in both length and flexibility among the screened 
ligands, which guaranteed their interaction with more active sites in TcAChE, and got 
higher Fitness Scores and inhibitory activities. 
 
Comp x n R1 R2 Fitness score 
8a 1 1 OCH3 H 75.41 
8b 1 2 OCH3 H 74.63 
8c 1 1 H CH2OH 72.62 
8d 1 3 OCH3 H 72.35 
8e 2 1 H CH2OH 71.47 
8f 2 1 OCH2CH3 CH2OH 71.06 
8g 2 1 OCH3 CH2OH 70.86 
8h 1 2 H CH2OH 70.39 
8i 1 2 H H 69.40 
8j 1 1 H H 67.62 
donepezil - - - - 68.53 
Corydaline - - - - 56.26 
Table 1. Rank and Fitness Score of the top 10 tetrahydroisoquinoline derivatives 
       
                                          (a)                                                                         (b) 
Fig. 5. Binding mode of Corydaline (a) and compound 7(b) ?ball and stick? on 
TcAChE?stick?.The active site was marked in purple, and the peripheral “anionic” site 
was marked in orange.  
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4. Conclusion 
On basis of the former research, Corydaline was used as lead compound. In the reserves of 
Protons turn nitrogen, the C ring of Corydaline was opened in order to get a series of 
derivatives. The virtual ligands with the respective substituent groups of -OH, -OCH3, 
benzyl etc, and different length with 2- to 7- linkages were designed from alkaloids of 
Corydaline as potential acetylcholinesterase inhibitors. Such derivatives are able to interact 
with both active site and PAS in the TcAChE. Such design may increase the flexibility and 
affinity of the virtual ligands to interact with both central catalytic site and peripheral site in 
the TcAChE more favourably.  
Molecular modelling obtained by GOLD suggests that by means of virtual screening, the 
compounds can bind with both catalytic anionic site and PAS in the TcAChE. The modes of 
binding were cation-π interaction and hydrophobic interaction. The mode was significant for 
the further optimization of Corydaline as well as the design of the novel following drugs.  
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